HVC
BMY icon

Healthcare Value Capital’s Bristol-Myers Squibb BMY Stock Holding History

Healthcare Value Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$2.96M Hold
50,000
– – 5.84% 9
2021
Q2 		$3.34M Buy
50,000
+25,000
+100% +$1.63M 6.66% 5
2021
Q1 		$1.58M Buy
+25,000
New +$1.56M 3.51% 14

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Healthcare Value Capital's BMY Position: Q3 2021 in Review

Healthcare Value Capital held its Bristol-Myers Squibb (BMY) position steady in Q3 2021 at 50,000 shares worth $2.96M. The position accounts for 5.84% of the portfolio, ranked #9.

Healthcare Value Capital first reported a position in BMY in Q1 2021 and has held it in 3 quarters since. The position peaked at $3.34M in Q2 2021. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

  • Healthcare Value Capital held 50,000 shares of Bristol-Myers Squibb worth $2.96M as of Q3 2021.
  • Healthcare Value Capital left its Bristol-Myers Squibb share count unchanged in Q3 2021.
  • Bristol-Myers Squibb made up 5.84% of Healthcare Value Capital's portfolio in Q3 2021, its #9 holding.
  • Healthcare Value Capital first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 3 quarters since.
  • Healthcare Value Capital's Bristol-Myers Squibb position peaked at $3.34M in Q2 2021.
  • 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.